b W e acknowledge the letter by Dortet et al. (1) in response to our evaluation of the Carba NP test (2), performed in two independent Canadian laboratories (the National Microbiology Laboratory, the national reference lab, and Public Health Ontario, a provincial reference lab).
ducers, isolates that we were easily able to detect in our study (only in the study reported in reference 7 was one OXA-48-like producer included).
We agree with Dortet et al. that the Carba NP test is rapid, inexpensive, and easy to perform, but we want to highlight the limitations related to its sensitivity, particularly against ␤-lactamases with weak carbapenemase activity (e.g., OXA-48-like, SME-1, or GES-5) or expressed in mucoid cells. We encourage other investigators to conduct further studies using the Carba NP test with carbapenemases displaying weak activity against the carbapenems or displaying a mucoid phenotype. In addition, we hope that the modifications that the authors will soon publish can solve the detection problems that we found in our evaluation.
